203 related articles for article (PubMed ID: 32441830)
1. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19.
Guarneri C; Venanzi Rullo E; Gallizzi R; Ceccarelli M; Cannavò SP; Nunnari G
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e449-e450. PubMed ID: 32441830
[No Abstract] [Full Text] [Related]
2. Dermatological findings in SARS-CoV-2 positive patients: An observational study from North India.
Dalal A; Jakhar D; Agarwal V; Beniwal R
Dermatol Ther; 2020 Nov; 33(6):e13849. PubMed ID: 32543757
[TBL] [Abstract][Full Text] [Related]
3. Familial clustering of COVID-19 skin manifestations.
Tatu AL; Nadasdy T; Bujoreanu FC
Dermatol Ther; 2020 Nov; 33(6):e14181. PubMed ID: 32794366
[TBL] [Abstract][Full Text] [Related]
4. Urticaria in the times of COVID-19.
Kaushik A; Parsad D; Kumaran MS
Dermatol Ther; 2020 Nov; 33(6):e13817. PubMed ID: 32531079
[No Abstract] [Full Text] [Related]
5. Cutaneous Manifestations of COVID-19: A Report from the United Arab Emirates.
Galadari I; Marzooqi AA; Naeem AA; Ali S; Adawi M; Galadari H
Skinmed; 2020; 18(4):218-220. PubMed ID: 33032685
[TBL] [Abstract][Full Text] [Related]
6. The Lingering Effects of COVID-19.
Am J Nurs; 2020 Dec; 120(12):15. PubMed ID: 33214356
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Australia: Epidemiology Report 30: Fortnightly reporting period ending 22 November 2020.
COVID-19 National Incident Room Surveillance Team
Commun Dis Intell (2018); 2020 Nov; 44():. PubMed ID: 33267752
[No Abstract] [Full Text] [Related]
8. [Are there cutaneous manifestations of SARS-CoV-2?].
Drerup KA; Gläser R
Hautarzt; 2020 Sep; 71(9):734-736. PubMed ID: 32778924
[No Abstract] [Full Text] [Related]
9. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19.
Askin O; Altunkalem RN; Altinisik DD; Uzuncakmak TK; Tursen U; Kutlubay Z
Dermatol Ther; 2020 Nov; 33(6):e13896. PubMed ID: 32579756
[TBL] [Abstract][Full Text] [Related]
10. Postmortem conjunctival and nasopharyngeal swabs in SARS-CoV-2 infected and uninfected patients.
Fuest M; Boor P; Knuechel R; ; Walter P; Salla S
Acta Ophthalmol; 2021 Jun; 99(4):e615-e617. PubMed ID: 32767497
[No Abstract] [Full Text] [Related]
11. The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic.
Ciccullo A; Borghetti A; Dusina A; Segala FV; Visconti E; Tamburrini E; Cauda R; Di Giambenedetto S
HIV Med; 2021 Jan; 22(1):e3-e4. PubMed ID: 32876390
[No Abstract] [Full Text] [Related]
12. Cutaneous manifestations of COVID-19 in the Franche-Comté region of France: A monocentric study.
Jacquin-Porretaz C; Ducournau A; Dupond AS; Nardin C; Aubin F; Courtieu C;
Ann Dermatol Venereol; 2021 Jun; 148(2):124-126. PubMed ID: 33541738
[No Abstract] [Full Text] [Related]
13. Cutaneous manifestations of viral outbreaks.
Bothra A; Maheswari A; Singh M; Pawar M; Jodhani K
Australas J Dermatol; 2021 Feb; 62(1):27-36. PubMed ID: 32895964
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Australia: Epidemiology Report 32: Four-week reporting period ending 3 January 2021.
COVID-19 National Incident Room Surveillance Team
Commun Dis Intell (2018); 2021 Jan; 45():. PubMed ID: 33460555
[No Abstract] [Full Text] [Related]
15. Skin findings in the COVID-19 pandemic in the Region of Murcia.
Pérez-Suárez B; Martínez-Menchón T; Cutillas-Marco E
Med Clin (Barc); 2020 Jul; 155(1):41-42. PubMed ID: 32446684
[No Abstract] [Full Text] [Related]
16. COVID toes and other cutaneous manifestations of COVID-19.
Rose-Sauld S; Dua A
J Wound Care; 2020 Sep; 29(9):486-487. PubMed ID: 32924822
[No Abstract] [Full Text] [Related]
17. Cutaneous Endothelial Dysfunction and Complement Deposition in COVID-19.
Tammaro A; Adebanjo GAR; Del Nonno F; Pezzuto A; Ramirez-Estrada S; Parisella FR; Rello J; Scarabello A
Am J Dermatopathol; 2021 Mar; 43(3):237-238. PubMed ID: 33055532
[No Abstract] [Full Text] [Related]
18. Histopathological findings in COVID-19-induced cutaneous lesions. Clinicopathological correlation of SARS-CoV-19 dermatologic patterns: review of the literature.
Nieto-Benito LM; Hernández de la Torre-Ruiz E; Balaguer-Franch I; Rosell-Díaz ÁM; Mateos-Mayo A; Herrero-Sanchez A; Lacasta-Plasín C; García-Piqueras P; Barchino-Ortiz L; Bergón-Sendín M; Pulido-Pérez A; Baniandrés-Rodríguez O; Rodriguez-Lomba E; Molina-Lopez I; Suárez-Fernandez R
Australas J Dermatol; 2021 Feb; 62(1):e98-e101. PubMed ID: 32920868
[TBL] [Abstract][Full Text] [Related]
19. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review.
Docampo-Simón A; Sánchez-Pujol MJ; Juan-Carpena G; Palazón-Cabanes JC; Vergara-De Caso E; Berbegal L; Poveda-Montoyo I; Pastor-Tomás N; Mataix-Díaz J; Terencio-Alemany C; Martínez-Torres A; Miralles-Botella J; Blanes-Martínez M; González-Villanueva I; Betlloch-Mas I
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):e445-e447. PubMed ID: 32452545
[No Abstract] [Full Text] [Related]
20. Cutaneous susceptibility to SARS-CoV-2 infection according to the expression of viral entry factors in the skin.
Garduño-Soto M; Choreño-Parra JA
Gac Med Mex; 2020; 156(4):354-357. PubMed ID: 32831324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
